PhosphoLean May Encourage Dieting Compliance

New research published in Lipids in Health and Disease suggests that Chemi Nutra’s (White Bear Lake, MN) PhosphoLean ingredient may improve dieting compliance by way of mood improvement.

Phospholean is a proprietary blend of N-oleyl-phosphatidylethanolamine (NOPE) and epigallocatechin-3-gallate (EGCG) from green tea extract. And while PhosphoLean studies haven’t yet demonstrated weight loss benefits, they reveal a trend towards greater diet compliance with the ingredient.

Most recently, 34 overweight adults were assigned to a daily intake of 300 mg of PhosphoLean or placebo for 8 weeks. Subjects were encouraged to consume a daily diet of 500 kcal or 30% fewer calories than they previously consumed (measured according to a three-day dietary recall). While weight loss did not differ significantly between the two treatment groups, PhosphoLean was associated with greater adherence to dieting (only up to week 4), significantly improved mood, and significantly decreased feelings of fatigue and confusion.

Chemi Nutra president Scott Hagerman says that these cognitive improvements can translate into a greater willingness to diet. “Although the results of this study were not quite as impressive as we anticipated, it did show once again that consumption of PhosphoLean NOPE+EGCG allowed subjects to stay on their diets with less stress, better mood, and improved feelings of fatigue and confusion,” said Hagerman. “It is well known that calorie-restrictive dieting can be very, very stressful, and, largely because of this, approximately 30% of all dieters fail in the first 5–10 days.”

An earlier study on 138 obese and overweight subjects shows that subjects who consumed PhosphoLean for 8 weeks experienced only a 6% drop-out rate compared to a 27% drop-out rate with placebo.